lung cancer

BERLIN — September 9, 2026 Bayer announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval...

Thousand Oaks, California, USA, September 8, 2026 Amgen and AstraZeneca have announced positive results from the Phase 3 DeLLphi-305...

BOSTON, Massachusetts — September 8, 2026 Verastem Oncology announced plans to host an investor event and webcast on October...

REDWOOD CITY, Calif., Sept. 2, 2026 Revolution Medicines, Inc. (Nasdaq: RVMD), a commercial-stage oncology company focused on RAS-driven cancers,...

Sydney, Australia, September 1, 2026 Kazia Therapeutics Limited has reported new preclinical and translational findings suggesting that its investigational...

Hong Kong, Shanghai, China, and Florham Park, New Jersey, August 31, 2026 HUTCHMED (China) Limited has announced positive high-level...

SAN ANTONIO, September 1, 2026 bioAffinity Technologies, Inc. is advancing the potential use of its noninvasive CyPath® Lung test...

Hong Kong, Shanghai & Florham Park, NJ – August 31, 2026 HUTCHMED (China) Limited announced positive high-level results from...

North Chicago, Illinois, USA, August 21, 2026 AbbVie has announced new clinical, translational and real-world research findings that will...

Redwood City, California, August 20, 2026 Galvanize Therapeutics, Inc. has announced new peer-reviewed evidence suggesting that its Aliya® pulsed...